work was supported by the Center for HIV/AIDS Vaccine Immunology (CHAVI) grant A1067854-03.Additional support came from the Medical Research Human Immunology Unit, the National Institute for Health Research, Oxford Biomedical Research Centre and grants 38643 and 37874 from the Bill and Melinda Gates Foundation.A.J.M. and P.B. are Jenner Investigators and P.B. is supported by a Jenner Fellowship.G.D.T is supported by the US National Institutes of Health, grants RO1AI052779, U19AI067854, AI068618 and AI64518 and the Bill and Melinda Gates Foundation (grant 38619).We are grateful to members of the CHAVI Scientific Leadership Group, N. Letvin, M. Cohen, J. Sodroski, D. Goldstein and G. Shaw for scientific input and for reviewing this manuscript, and to the CHAVI Clinical Core Investigators and their patients for participation in the CHAVI studies cited in this review.